The FDA has granted platform technology designation to Precigen's AdenoVerse immunotherapeutic platform, used in its first commercial product PAPZIMEOS. This designation recognizes the platform's adaptability for treating various HPV-related cancers and other diseases, enabling Precigen to leverage existing data and manufacturing knowledge to accelerate development of future therapies. It also allows earlier and more frequent FDA engagement, reducing duplicative work and speeding regulatory review. Precigen's AdenoVerse portfolio includes ongoing Phase 2 trials for HPV-associated cancers and an approved therapy for recurrent respiratory papillomatosis.
Precigen's AdenoVerse platform technology designation by the FDA provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Sep 21, 2026 17:21 WIB: out of 92 priced US health-sector stocks, 46 rose and 29 fell. Notable movers include ClearPoint Neuro Inc (CLPT) at USD 14.10 with a 1-day change of +1.95%, 10X Genomics Inc (TXG) at USD 77.69 with +1.42%, and Abeona Therapeutics Inc (ABEO) at USD 5.46 with -1.97%. The typical hold time on Pluang ranges from 10 to 94 days among these stocks.
Accenture's stock fell 4.73% to $181.29 after Guggenheim reiterated a Neutral rating, citing that the stock price has outpaced the company's actual business performance. Analysts point to weak customer demand, fewer job postings, and a cautious mid-m...
Thryv Holdings is selling its traditional print directory business for $142 million to focus on business automation software for small and medium businesses. CEO Walsh Joe bought 25,000 shares at $1.80 each, increasing his stake to 788,099 shares, si...
Skeleton Coast Uranium Corp. announced a non-brokered private placement offering up to 33.3 million units at $0.15 each, aiming to raise $5 million. Each unit includes one common share and half a warrant, with warrants exercisable at $0.20 for 24 mon...
Bitcoin surged more than 5% to surpass $85,000, its highest level since January, following the failure of the CLARITY Act in the US Senate. The bill, aimed at regulating crypto markets, did not receive enough votes to avoid a filibuster, leaving digi...
Midnight Sun Mining Corp has entered an earn-in agreement to acquire up to an 80% interest in the Mulundu Licence, a 62 square kilometre property adjacent to its Solwezi Project in Zambia. Geophysical data suggests the Dumbwa mineralized trend may ex...
